scholarly journals High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow

2001 ◽  
Vol 28 (11) ◽  
pp. 1023-1029 ◽  
Author(s):  
JL Klein ◽  
C Hamm ◽  
RD Dansey ◽  
C Karanes ◽  
E Abella ◽  
...  
1994 ◽  
Vol 5 (9) ◽  
pp. 795-802 ◽  
Author(s):  
E. van der Wall ◽  
D.J. Richel ◽  
M.J. Holtkamp ◽  
I.C.M. Slaper-Cortenbach ◽  
C.E. van der Schoot ◽  
...  

2005 ◽  
Vol 91 (3) ◽  
pp. 237-240 ◽  
Author(s):  
Alfredo Tartarone ◽  
Jenna Wunder ◽  
Gianpiero Romano ◽  
Raffaele Ardito ◽  
Giovanni lodice ◽  
...  

High-dose chemotherapy followed by autologous bone marrow or peripheral blood progenitor cell transplantation represents a recognized option in the treatment of solid tumors and hematologic diseases. Patients receiving high-dose chemotherapy are traditionally supported with parenteral nutrition with the aim to prevent malnutrition secondary to gastrointestinal toxicity and metabolic alterations induced by the conditioning regimens. Nevertheless, well-defined guidelines for its use in this clinical setting are lacking and there are several areas of controversy.


Sign in / Sign up

Export Citation Format

Share Document